Estudo clínico iniciado com novo spray nasal codinome APR-AOS2020 em pacientes com COVID-19 moderada ...Middle East

BALERNA, Suíça, 13 de maio de 2021 /PRNewswire/ -- A APR Applied Pharma Research S.A. (APR), líder no desenvolvimento de tecnologias e sistemas de distribuição de medicamentos farmacêuticos e produtos inovadores derivados dos mesmos, anunciou hoje o início de um estudo clínico principal...

Hence then, the article about estudo clinico iniciado com novo spray nasal codinome apr aos2020 em pacientes com covid 19 moderada was published today ( Thursday 13/05/2021 - 08:48 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Estudo clínico iniciado com novo spray nasal codinome APR-AOS2020 em pacientes com COVID-19 moderada )

Also on site :

• Inside the chaos at Canoo, the zero-revenue, cash-burning EV company that just inked a major deal with Walmart
• Zelensky’s inner circle accused of war profiteering
• ServiceNow just unveiled an AI workforce that can run your entire company: ‘Enterprises need AI that senses, decides, and securely acts’